Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYOBLOC in Cervical Dystonia
NCT00702754Phase 4Completed
- Sponsor
- US WorldMeds
- Start
- Jun 2001
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, open-label, single-arm trial of botulinum toxin type b in cervical dystonia (CD), sponsored by US WorldMeds. Primary endpoint: Treatment Assessment Scale at 4 weeks. Started Jun 2001; status: completed.
02
Drugs
botulinum toxin type b
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT00702754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00702754.